Maintenance pemetrexed in nonsmall cell lung carcinoma: Outcome analysis from a tertiary care center by Avinash Vijaykumar Pandey, Deepa Susan Phillip, Vanita Noronha, Amit Joshi, Amit Janu, Nirmala Jambekar, Rajesh Kaushal, Abhishek Mahajan, Kumar Prabhash

Subjects: Get full text

Characterization of renal injury in non‐squamous non‐small cell lung cancer patients treated with pemetrexed: A single‐center retrospective study by Yang Wu, Kang Miao, Minjiang Chen, Yan Xu, Wei Zhong, Hanping Wang, Xiaoyan Si, Xiaotong Zhang, Li Zhang, Jing Zhao, Mengzhao Wang

Subjects: Get full text

Acute pancreatitis caused by pemetrexed, carboplatin, and gemcitabine in a patient with lung cancer: A rare case report by Vishal Kulkarni, B J Srinivasa, P K Kiran, Vinu Sarathy, S Shivakumar Swamy, Radheshyam Naik

Subjects: Get full text

Tyrosine kinase inhibitor versus physician choice chemotherapy in second-line epidermal growth factor receptor mutation non-small cell lung cancer: Post hoc analysis of randomized... by Vanita Noronha, Avinash Pandey, Vijay Patil, Amit Joshi, Anuradha Bharat Choughule, Atanu Bhattacharjee, Rajiv Kumar, Supriya Goud, Sucheta More, Anant Ramaswamy, Ashay Karpe, Nikhil Pande, Arun Chandrasekharan, Alok Goel, Vikas Talreja, Abhishek Mahajan, Amit Janu, Nilendu Purandare, Kumar Prabhash

Subjects: Get full text

Long-term survival after salvage pemetrexed for refractory primary T-cell lymphoma of the CNS by Andy Liu, Huda Alalami, Xuemo Fan, Chirag Patil, Jaya M Gill, Santosh Kesari, Jethro Hu

Subjects: Get full text

The real-world safety profile of pemetrexed and platinum with or without pembrolizumab: insights from a comparative analysis of FAERS database by Shun Li, Zhifei Huang, Xiaoyu Zhong, Yan Zhou, Hao Jiang

Subjects: Get full text

Significant clinical benefit of pemetrexed-based chemotherapy for advanced diffuse malignant peritoneal mesothelioma: A case presentation by Milena Peitl, Sven Seiwerth, Martina Bašić-Koretić, Fedor Šantek

Subjects: Get full text

Use of combined chemotherapy and immunotherapy improves pulmonary arterial hypertension by Tejaswini P. Reddy, Roberto Barrios, Eric Bernicker, Wei Qian, Jenny Chang, Zeenat Safdar

Subjects: Get full text

PD-L1 pfeRNAs as blood-based predictors of treatment response of unresectable malignant pleural mesothelioma patients administered Durvalumab with cisplatin and pemetrexed as first... by Andrei Gurau, Suguru Yamauchi, Kaitlyn Ecoff, Kristen P. Rodgers, James R. Eshleman, Charles Conover Talbot Jr, Peng Huang, Joshua Choi, Patrick M. Forde, Valsamo Anagnostou, Malcolm Brock, Yuping Mei

Subjects: Get full text

A rare presentation of the diffuse dermal mucinosis in adenocarcinoma of the lungs treated with pembrolizumab and pemetrexed by Karen Koch, MBChB (UCT), FCDerm (SA), FRACP, MMed (Derm), Kamal Solanki, MBBS (MPMSU), FRACP, Julia Zhu, MBChB

Subjects: Get full text

Postmarketing safety evaluation of pemetrexed using FAERS and JADER databases by Luo Lv, Xiangyang Wu, Yubo Ren, Yuli Guo, Haixiong Wang, Xiaofang Li

Subjects: “…Pemetrexed…”
Get full text

Intrathecal administration of PD-1 inhibitor combined with pemetrexed for leptomeningeal metastases from breast cancer: a case report by Yushan Huang, Guozi Yang, Miaomiao Liu, Panpan Tai, Xiao Chen, Min Liu, Zhenyu Pan

Subjects: Get full text

RESULTS OF TREATMENT OF PATIENTS WITH LOCALLY ADVANCED AND METASTATIC NON-SQUAMOUS CELL NON-SMALL-CELL LUNG CARCINOMA WITH PEMETREXED (BY OWN EXPERIENCE) by L. Yu. Vladimirova, A. E. Storozhakova, S. N. Kabanov, E. A. Kalabanova

Subjects: “…non-small-cell lung cancer, adenocarcinoma of the lung, egfr mutation, chemotherapy, pemetrexed…”
Get full text

Systemic Antifolate Chemotherapy Does Not Select for Fluconazole-Resistant <i>Candida</i>: A Multicenter Clinical Study by Dawid Żyrek, Joanna Nowicka, Magdalena Pajączkowska, Mariola Paściak, Katarzyna Machnik, Tomasz Werner, Zygmunt Konieczny, Piotr Jędrzejczak, Dominika Raźniewska, Gabriela Fijałkowska, Michał Piątek, Barbara Radecka, Kinga Żyrek, Elżbieta Woźniak-Grygiel, Iwona Dzieńdziora-Urbińska

Subjects: Get full text

Intrathecal pemetrexed chemotherapy combined with systemic therapy in patients with non-small cell lung cancer and leptomeningeal metastases: a retrospective study by Wenjuan Zhong, Wenjuan Zhong, Longqiu Wu, Longqiu Wu, Zhengang Qiu, Zhengang Qiu, Wei Yu, Linfang Liu, Huaqiu Shi, Huaqiu Shi, Shugui Wu

Subjects: Get full text

Correction: The efficacy and safety of intrathecal pemetrexed for leptomeningeal metastasis from non-small cell lung cancer: a single-arm meta-analysis of Chinese patients by Yushi Zhao, Xueqin Gao, Yong Han

Subjects: “…pemetrexed…”
Get full text

Cost-effectiveness of pemetrexed in combination with cisplatin as first line treatment for patients with advanced non-squamous non-small-cell by Jonathan González García, Fernando Gutiérrez Nicolás, Gloria Julia Nazco Casariego, Cristina Valcárcel Nazco, Jose Norberto Batista López, Juana Oramas Rodríguez

Subjects: Get full text

The efficacy and safety of intrathecal pemetrexed for leptomeningeal metastasis from non-small cell lung cancer: a single-arm meta-analysis of Chinese patients by Yushi Zhao, Xueqin Gao, Yong Han

Subjects: “…pemetrexed…”
Get full text

Experience of pemetrexed in maintenance therapy for metastatic lung adenocarcinoma by L. Yu. Vladimirova, A. E. Storozhakova, E. A. Kalabanova, P. N. Meshcheryakov, S. V. Oskin, S. N. Kabanov, N. Yu. Samaneva, Ya. V. Svetitskaya, A. V. Tishina

Subjects: Get full text

Cytotoxic mechanisms of pemetrexed and HDAC inhibition in non-small cell lung cancer cells involving ribonucleotides in DNA by Tobias Solli Iveland, Lars Hagen, Mirta Mittelstedt Leal de Sousa, Nina Beate Liabakk, Per Arne Aas, Animesh Sharma, Bodil Kavli, Geir Slupphaug

Subjects: Get full text